Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

G Livingston, J Huntley, A Sommerlad, D Ames… - The lancet, 2020 - thelancet.com
Executive summary The number of older people, including those living with dementia, is
rising, as younger age mortality declines. However, the age-specific incidence of dementia …

Arterial hypertension

S Brouwers, I Sudano, Y Kokubo, EM Sulaica - The Lancet, 2021 - thelancet.com
Arterial hypertension is the most important contributor to the global burden of disease;
however, disease control remains poor. Although the diagnosis of hypertension is still based …

Association of systolic blood pressure with dementia risk and the role of age, U-shaped associations, and mortality

JW van Dalen, C Brayne, PK Crane… - JAMA internal …, 2022 - jamanetwork.com
Importance The optimal systolic blood pressure (SBP) to minimize the risk of dementia in
older age is unknown. Objective To investigate whether the association between SBP and …

[HTML][HTML] Promoting successful cognitive aging: a ten-year update

TJ Krivanek, SA Gale, BM McFeeley… - Journal of …, 2021 - content.iospress.com
A decade has passed since we published a comprehensive review in this journal
addressing the topic of promoting successful cognitive aging, making this a good time to …

Shared risk factors between dementia and atherosclerotic cardiovascular disease

LT Nordestgaard, M Christoffersen… - International Journal of …, 2022 - mdpi.com
Alzheimer's disease is the most common form of dementia, and the prodromal phases of
Alzheimer's disease can last for decades. Vascular dementia is the second most common …

A roadmap to build a phenotypic metric of ageing: insights from the Baltimore Longitudinal Study of Aging

PL Kuo, JA Schrack, MD Shardell… - Journal of Internal …, 2020 - Wiley Online Library
Over the past three decades, considerable effort has been dedicated to quantifying the pace
of ageing yet identifying the most essential metrics of ageing remains challenging due to …

How much lowering of blood pressure is required to prevent cardiovascular disease in patients with and without previous cardiovascular disease?

D Canoy, M Nazarzadeh, E Copland, Z Bidel… - Current cardiology …, 2022 - Springer
Abstract Purpose of Review To review the recent large-scale randomised evidence on
pharmacologic reduction in blood pressure for the primary and secondary prevention of …

[HTML][HTML] Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an …

K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy… - The lancet, 2021 - thelancet.com
Background The effects of pharmacological blood-pressure-lowering on cardiovascular
outcomes in individuals aged 70 years and older, particularly when blood pressure is not …

Blood pressure in frail older adults: associations with cardiovascular outcomes and all-cause mortality

JAH Masoli, J Delgado, L Pilling, D Strain… - Age and …, 2020 - academic.oup.com
Background Blood pressure (BP) management in frail older people is challenging. An
randomised controlled trial of largely non-frail older people found cardiovascular and …

Age of hypertension onset: overview of research and how to apply in practice

K Suvila, V Langen, S Cheng, TJ Niiranen - Current hypertension reports, 2020 - Springer
Abstract Purpose of Review To review the current evidence on research related to age of
hypertension onset—its definition, correlates, heritability, and association with adverse …